Who backs Bright Peak Therapeutics?
12 investors| Investor | Type |
|---|---|
| Fidelity Management & Research Company | Asset manager |
| RA Capital Management | Asset manager |
| KB Investment | Venture capital |
| Alexandria Venture Investments | Other |
| BlackRock | Other |
| Qatar Investment Authority | Asset manager |
| Venrock | Venture capital |
| Johnson & Johnson JJDC | Venture capital |
| The Invus Group | PE / buyout |
| Versant Ventures | Venture capital |
| + 2 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Bright Peak Therapeutics investors
12 investors are on record for Bright Peak Therapeutics, including Fidelity Management & Research Company, RA Capital Management, KB Investment and Alexandria Venture Investments. By type, the record holds 4 venture capital firms, 3 asset managers and 1 private equity firm. The Series C in Jun 2024 drew 9 investors.
Free account
More of Bright Peak Therapeutics with a free account
- ·The complete investor list: 12 names
- ·Watch Bright Peak Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Bright Peak Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View